SEC Form 4 · accession 0001437749-15-022532
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andreas Voss
Director
Period of report
Dec 15, 2015
Accepted (ET)
Dec 18, 2015 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000749647
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Celsion Corporation Common StockF1,F2 | $1.78 | Dec 15, 2015 | A | 30,000 | A | Dec 15, 2016 | Dec 15, 2025 | Celsion Corporation Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Represents the closing price of Celsion Corporation Common Stock on the date of grant.
- F2The option vests in thirds on December 15, 2016, December 15, 2017 and December 15, 2018.